TAB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.100400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.117840E-01
Normal-vs-Stage2
2.437200E-01
Normal-vs-Stage3
3.929500E-02
Normal-vs-Stage4
9.596800E-01
Stage1-vs-Stage2
4.425600E-01
Stage1-vs-Stage3
4.046200E-01
Stage1-vs-Stage4
1.464960E-01
Stage2-vs-Stage3
1.895650E-01
Stage2-vs-Stage4
2.120000E-01
Stage3-vs-Stage4
7.974100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.915610E-01
Normal-vs-AfricanAmerican
6.024800E-01
Normal-vs-Asian
1.666800E-01
Caucasian-vs-AfricanAmerican
3.825200E-01
Caucasian-vs-Asian
4.106800E-01
AfricanAmerican-vs-Asian
2.745400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.186200E-01
Normal-vs-Female
2.188400E-01
Male-vs-Female
7.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.405000E-01
Normal-vs-Age(41-60Yrs)
5.243000E-01
Normal-vs-Age(61-80Yrs)
1.284010E-01
Normal-vs-Age(81-100Yrs)
9.375700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.765400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.167600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.858800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.876500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.728100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.146200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.517000E-01
Normal-vs-Daily Drinker
1.925760E-02
Normal-vs-Weekly Drinker
1.775960E-01
Normal-vs-Occasional Drinker
4.510800E-01
Normal-vs-Social Drinker
5.592400E-01
Non Drinker-vs-Daily Drinker
1.387160E-01
Non Drinker-vs-Weekly Drinker
9.983400E-01
Non Drinker-vs-Occasional Drinker
3.016200E-01
Non Drinker-vs-Social Drinker
3.132400E-01
Daily Drinker-vs-Weekly Drinker
2.028000E-01
Daily Drinker-vs-Occasional Drinker
2.640100E-02
Daily Drinker-vs-Social Drinker
7.166400E-02
Weekly Drinker-vs-Occasional Drinker
4.001800E-01
Weekly Drinker-vs-Social Drinker
4.201000E-01
Occasional Drinker-vs-Social Drinker
9.311400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.370800E-01
Normal-vs-Grade 2
7.050300E-02
Normal-vs-Grade 3
7.524000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.356300E-02
Grade 1-vs-Grade 3
3.934000E-02
Grade 1-vs-Grade 4
2.370800E-01
Grade 2-vs-Grade 3
4.959000E-01
Grade 2-vs-Grade 4
7.050300E-02
Grade 3-vs-Grade 4
7.524000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.345800E-01
Normal-vs-NonDiabetic
1.698020E-01
Diabetic-vs-NonDiabetic
7.072000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.712770E-01
Normal-vs-NoPancreatitis
1.772620E-01
Pancreatitis-vs-NoPancreatitis
8.797400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.021200E-01
Normal-vs-N1
2.391000E-01
N0-vs-N1
4.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.422600E-01
Normal-vs-TP53-NonMutant
3.033400E-01
TP53-Mutant-vs-TP53-NonMutant
4.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
